Understanding the Market | XUANZHUBIO-B surged over 14%, rising more than 2.3 times from the offering price as the company enters a period of commercial explosion this year
I'm PortAI, I can summarize articles.
XUANZHUBIO-B's stock price rose more than 14% in the afternoon, reaching a high of HKD 38.8, an increase of over 234% compared to the offering price of HKD 11.6. As of the time of writing, the stock price is HKD 38.12, with a trading volume of HKD 32.2915 million. The company was spun off from Sihuan Pharmaceutical and is actively developing a variety of drugs, expecting to enter a commercialization boom period in 2025, forming a product matrix centered on digestive and oncology drugs
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments